Shenzhen Xipu Network Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Xipu Network Technology Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DPMELODY, TAMINSTY, and CUTIEPLUSU. The owner is based in Shenzhen City.
Rm401,No.17,Chang Keng Si Xiang,
Bantian St., Longgang Dist.,
Shenzhen City 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Xipu Network Technology Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shenzhen Xipu Network Technology Co., Ltd. have?
Shenzhen Xipu Network Technology Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Shenzhen Xipu Network Technology Co., Ltd. file in?
Shenzhen Xipu Network Technology Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 25 covers clothing, footwear, headgear.
What are Shenzhen Xipu Network Technology Co., Ltd.'s most well-known trademarks?
Shenzhen Xipu Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as DPMELODY, TAMINSTY, and CUTIEPLUSU. These are among 4 currently registered trademarks in the portfolio.
What is Shenzhen Xipu Network Technology Co., Ltd.'s trademark registration success rate?
Shenzhen Xipu Network Technology Co., Ltd. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.